Coca-Cola Consolidated, Inc.
COKE
$186.16
+0.39%
Coca-Cola Consolidated, Inc. is a major bottler and distributor of non-alcoholic beverages in the United States, operating within the Consumer Defensive sector. The company is a key anchor bottler for The Coca-Cola Company, holding exclusive territories and serving as a critical link in the production and distribution of a wide portfolio of sparkling and still beverages. The current investor narrative centers on the company's execution within a stable, mature industry, with recent attention likely focused on its ability to navigate inflationary cost pressures, manage its significant capital allocation decisions—including substantial share repurchases—and deliver consistent, albeit moderate, revenue growth in a competitive landscape.…
COKE
Coca-Cola Consolidated, Inc.
$186.16
Investment Opinion: Should I buy COKE Today?
Rating & Thesis: Hold. COKE presents a conflicted picture of strong fundamentals obscured by technical breakdown and valuation ambiguity, with insufficient analyst coverage to provide a clear anchor. The core thesis is that the stock is in a volatile consolidation phase after a major run-up, and investors should wait for either a confirmation of the bullish forward earnings story or a clearer technical bottom before committing new capital.
Supporting Evidence: The recommendation is supported by four key data points: 1) The extreme forward P/E of 4.37x suggests deep value if accurate, but is an outlier requiring verification. 2) Revenue growth remains positive at 9.03% YoY but is decelerating. 3) Profitability is solid with a 12.89% operating margin. 4) The stock trades at a reasonable Price-to-Sales of 1.56x and EV/EBITDA of 11.97x, which are not excessive for its sector. However, the severe -20.95% one-month return and breakdown from highs outweigh these positives in the near term.
Risks & Conditions: The two biggest risks are the failure of earnings to meet forward expectations and continued technical selling pressure breaking the $163 support level. This Hold would upgrade to a Buy if the stock stabilizes above $180 with volume, confirming the forward earnings narrative, or if the forward P/E proves accurate in upcoming reports. It would downgrade to a Sell if quarterly revenue growth falls below 5% or if the stock breaches $160, targeting the $150s. Based on current multiples and growth, the stock appears fairly valued to slightly overvalued relative to its own history, but potentially undervalued on forward estimates—a dichotomy that necessitates caution.
Sign up to view all
COKE 12-Month Price Forecast
The outlook for COKE is highly bifurcated, leading to a neutral stance. The stock's fate hinges on whether its forward earnings materialize to justify its seemingly cheap valuation. The strong cash generation and defensive profile are positive, but these are currently overshadowed by severe price momentum breakdown and the uncertainty surrounding its leveraged balance sheet. Confidence is medium due to the lack of analyst consensus. The stance would upgrade to bullish on a confirmed earnings beat and technical recovery above $200, or turn bearish on an earnings miss and break below the $150 support level.
Wall Street consensus
Most Wall Street analysts maintain a constructive view on Coca-Cola Consolidated, Inc.'s 12-month outlook, with a consensus price target around $242.01 and implied upside of +30.0% versus the current price.
Average Target
$242.01
1 analysts
Implied Upside
+30.0%
vs. current price
Analyst Count
1
covering this stock
Price Range
$149 - $242
Analyst target range
Insufficient analyst coverage available. Only one analyst provides estimates for COKE, with a revenue forecast of $7.23 billion. The lack of a consensus price target, recommendation, or meaningful recent rating actions (the latest institutional rating is from 2016) indicates very limited sell-side research coverage. This is typical for a smaller, regionally-focused bottler with a market cap of approximately $11.3 billion. Limited coverage can lead to higher volatility and less efficient price discovery, as the stock is less scrutinized by institutional investors. The wide dispersion in historical valuation multiples further underscores the uncertainty and lower visibility surrounding the stock's fair value.
Bulls vs Bears: COKE Investment Factors
The evidence is currently mixed but leans bearish in the near term due to severe technical deterioration and valuation uncertainty. The bull case is anchored in exceptional cash generation, a cheap forward earnings multiple, and a stable defensive business. The bear case is driven by a sharp price collapse, a leveraged balance sheet, and decelerating growth momentum. The single most important tension in the investment debate is the validity of the forward P/E of 4.37x. If the implied earnings surge materializes, the stock is deeply undervalued. If not, the current price decline may be justified, and the stock could re-rate closer to its higher trailing multiple, implying significant further downside.
Bullish
- Robust Free Cash Flow Generation: The company generated $620.3 million in trailing free cash flow, which is substantial relative to its $11.3B market cap, providing a strong cushion for dividends, buybacks, and debt service. This cash generation, paired with a 12.89% operating margin in Q4 2025, demonstrates a highly profitable and cash-generative core business.
- Attractive Valuation on Forward Earnings: The stock trades at a forward P/E of just 4.37x, suggesting the market is pricing in a significant earnings increase or is deeply undervaluing future profits. This is a steep discount to its own trailing P/E of 19.79x and suggests substantial upside if earnings projections materialize.
- Strong One-Year Price Momentum: COKE is up 58.13% over the past year, significantly outperforming the SPY's 27.04% gain by over 31 percentage points. This long-term relative strength indicates underlying fundamental strength and investor confidence in its business model.
- Stable, Defensive Business Model: As a Coca-Cola bottler, COKE operates in the stable Consumer Defensive sector with a low beta of 0.60, implying 40% less volatility than the market. Its Q4 revenue grew 9.03% YoY, showing resilience and pricing power in a mature industry.
Bearish
- Severe Technical Breakdown & Momentum Loss: The stock has fallen 20.95% in the past month and 16.69% over three months, significantly underperforming the SPY by -25.55% and -29.29%, respectively. It is trading 22.5% below its 52-week high of $219.65, signaling a potential trend reversal and heavy selling pressure.
- Negative Shareholder Equity & High Leverage: The debt-to-equity ratio is -4.06 due to negative shareholder equity, a result of aggressive share buybacks. This creates a technically leveraged balance sheet and could limit financial flexibility in a downturn, despite the strong cash flow.
- Revenue Growth Deceleration: While Q4 revenue grew 9.03% YoY, this represents a sequential deceleration from stronger growth earlier in 2025. The moderation in top-line growth raises questions about the sustainability of its recent price appreciation.
- Extremely Limited Analyst Coverage: Only one analyst provides estimates, with no consensus price target or rating. This lack of institutional scrutiny leads to higher volatility and less efficient price discovery, as evidenced by the stock's 24.66% maximum drawdown.
COKE Technical Analysis
The stock is in a volatile consolidation phase following a significant prior uptrend. Over the past year, COKE has delivered a strong 58.13% price appreciation, yet it is currently trading at approximately 77.5% of its 52-week range ($170.27 vs. a high of $219.65 and low of $105.21), indicating it has retreated meaningfully from recent highs. This positioning suggests the momentum from the prior uptrend has stalled, with the stock now testing levels that could represent either a value zone or a concerning breakdown. Recent momentum has turned sharply negative, with the stock down 20.95% over the past month and 16.69% over the past three months, a stark divergence from the positive one-year trend. This severe short-term underperformance, highlighted by a relative strength of -25.55 against the SPY over one month, signals significant selling pressure and potential trend exhaustion or reversal. Key technical support is anchored near the 52-week low of $105.21, while immediate overhead resistance sits at the recent 52-week high of $219.65. A decisive break below the recent May low of $163.43 could signal a deeper correction toward the $150 area, whereas a recovery above the $200 level would be needed to re-establish bullish momentum. The stock's beta of 0.60 indicates it is 40% less volatile than the broader market (SPY), which is unusually low for a stock exhibiting such sharp recent moves; this low beta may reflect its defensive sector but contrasts with the stock's own high intra-stock volatility as seen in the 24.66% maximum drawdown.
Beta
0.55
0.55x market volatility
Max Drawdown
-24.7%
Largest decline past year
52-Week Range
$105-$220
Price range past year
Annual Return
+73.7%
Cumulative gain past year
| Period | COKE Return | S&P 500 |
|---|---|---|
| 1m | +9.3% | +1.5% |
| 3m | -12.5% | +13.4% |
| 6m | +12.1% | +10.9% |
| 1y | +73.7% | +24.5% |
| ytd | +24.2% | +10.0% |
Bobby - Your AI Investment Partner
Get real-time data, AI-driven personalized investment analysis to make smarter investment decisions
COKE Fundamental Analysis
Revenue growth remains positive but has shown signs of deceleration in the most recent quarter. For Q4 2025, revenue was $1.904 billion, representing a year-over-year growth of 9.03%. However, this marks a slowdown from the stronger growth rates seen in prior quarters of 2025 (e.g., Q2 revenue grew 3.3% sequentially from Q1). The Nonalcoholic Beverage segment, which constitutes the vast majority of sales at $1.893 billion, is the sole driver of this growth, while the All Other segment is immaterial at $83.1 million. The growth trajectory suggests the company is gaining share or benefiting from pricing, but the pace is moderating. The company is solidly profitable with expanding margins. Net income for Q4 2025 was $137.3 million, yielding a net margin of 7.21%. Gross margin for the quarter was 38.21%, which is consistent with the full-year gross margin of 39.74%. More notably, operating income of $245.5 million translated to an operating margin of 12.89%, demonstrating healthy profitability after accounting for SG&A expenses of $482.0 million. The margin profile is stable and typical for a capital-intensive bottling and distribution business. The balance sheet exhibits significant leverage but is supported by robust cash generation. The debt-to-equity ratio is negative at -4.06 due to negative shareholder equity, a technical artifact often seen with aggressive share buybacks. More importantly, the company generated substantial free cash flow of $620.3 million on a trailing twelve-month basis, providing ample internal funding for growth, dividends ($21.4 million paid in Q4), and further capital returns. The current ratio of 1.26 indicates adequate short-term liquidity, though not excessive. The strong free cash flow yield mitigates the financial risk implied by the high leverage on the balance sheet.
Quarterly Revenue
$1.9B
2025-12
Revenue YoY Growth
+0.09%
YoY Comparison
Gross Margin
+0.38%
Latest Quarter
Free Cash Flow
$620252000.0B
Last 12 Months
Revenue & Net Income Trends (2 Years)
Revenue Breakdown
Open an Account, get $2 TSLA now!
Valuation Analysis: Is COKE Overvalued?
Given the company's positive net income, the primary valuation metric is the Price-to-Earnings (PE) ratio. The trailing PE ratio is 19.79x, while the forward PE is significantly lower at 4.37x. This massive gap suggests the market is anticipating a substantial increase in earnings, likely due to the lapping of one-time items or the full-year effect of recent profitability improvements, though the forward estimate should be viewed with caution given it is based on a single analyst. Compared to sector averages, COKE's trailing PE of 19.79x is difficult to contextualize without a provided industry average, but its Price-to-Sales (PS) ratio of 1.56x appears reasonable for a stable, asset-heavy distributor. The EV/EBITDA multiple of 11.97x also suggests a moderate valuation relative to operating cash flow generation. The stock does not appear to be trading at an extreme premium based on these sales and cash flow multiples. Historically, the stock's own valuation has fluctuated widely. The current trailing PE of 19.79x sits below the higher end of its historical range seen in recent quarters (e.g., 27.98x in Q1 2025) but above the lows near 10-12x from 2022-2023. This mid-range historical positioning suggests the market is pricing in a balanced outlook, neither excessively optimistic nor pessimistic, following the stock's significant price run-up and subsequent pullback.
PE
19.8x
Latest Quarter
vs. Historical
Low-End
5-Year PE Range 8x~76x
vs. Industry Avg
N/A
Industry PE ~N/A*
EV/EBITDA
13.5x
Enterprise Value Multiple
Investment Risk Disclosure
Financial & Operational Risks: COKE's primary financial risk stems from its leveraged capital structure, evidenced by negative shareholder equity (-4.06 debt-to-equity ratio) resulting from substantial share repurchases. While robust trailing free cash flow of $620.3 million provides a buffer, a sustained downturn or margin compression from inflationary pressures (gross margin dipped to 38.21% in Q4 from 39.74% annual) could strain its ability to service debt and continue aggressive capital returns. Furthermore, revenue concentration in the Nonalcoholic Beverage segment ($1.89B of $1.90B total Q4 sales) creates single-point dependency on the Coca-Cola portfolio's performance.
Market & Competitive Risks: The stock faces significant valuation compression risk. After a 58% one-year run-up, it has corrected sharply, but its trailing P/E of 19.79x may still be rich for a low-growth bottler if forward earnings disappoint. Its low beta of 0.60 suggests it should be less volatile, yet its recent -20.95% monthly drop shows high idiosyncratic risk, potentially due to its thin analyst coverage and low liquidity. Competitive risks are inherent in the capital-intensive bottling industry, where pricing power is limited by brand owners like Coca-Cola and large retailers.
Worst-Case Scenario: The worst-case scenario involves a 'perfect storm' where the anticipated earnings surge fails to materialize, revealing the forward P/E as misleadingly low. Simultaneously, a recession reduces beverage volumes, compressing the stable 12-13% operating margin. This could trigger a re-rating to a more typical bottler multiple on lower earnings, coupled with technical selling breaching key support. A realistic downside target is a retest of the 52-week low of $105.21, which would represent a -38% decline from the current price of $170.27. The stock's 24.66% maximum drawdown indicates it is capable of such moves.
FAQ
The key risks are, in order of severity: 1) Valuation & Earnings Risk: The forward P/E of 4.37x is based on a single analyst's estimate; an earnings miss could cause a violent multiple expansion and price drop. 2) Financial Leverage Risk: The negative shareholder equity (Debt/Equity of -4.06) indicates a balance sheet stretched by buybacks, limiting flexibility. 3) Technical & Momentum Risk: The stock is down 20.95% in one month and 16.69% in three months, indicating strong selling pressure that may not be over. 4) Low Visibility Risk: With only one analyst covering, the stock suffers from poor price discovery and can gap on news, as seen in its 24.66% max drawdown.
The 12-month forecast presents three scenarios. The Base Case (50% probability) sees the stock trading between $170 and $200 as it digests recent gains, with moderate earnings growth failing to justify the extreme forward multiple. The Bull Case (30% probability) targets $219 to $240, requiring earnings to surge and validate the low forward P/E, pushing the stock to new highs. The Bear Case (20% probability) warns of a drop to $105-$150 if earnings disappoint and technical support fails. The base case is most likely, implying a year of volatile, range-bound trading centered near current levels.
COKE's valuation is contradictory and depends entirely on the earnings metric used. On a trailing basis, it trades at a P/E of 19.79x and a P/S of 1.56x, which appears fairly valued to slightly rich for a mature bottler. However, its forward P/E of 4.37x suggests it is profoundly undervalued, implying the market expects a dramatic earnings increase. Compared to its own history, the stock is in a mid-range valuation following its 58% one-year run-up. The market is currently pricing in significant future growth; therefore, the stock is either undervalued on forward estimates or overvalued if those estimates fail to materialize.
COKE is a speculative buy at current levels, suitable only for investors with a high risk tolerance. The potential reward is significant if the forward P/E of 4.37x proves accurate, implying massive earnings growth. However, the risk is equally high given the stock's 20.95% drop in the past month, negative shareholder equity, and lack of analyst coverage. It could be a good buy for a contrarian investor betting on a mean reversion in price and realization of earnings, but most investors should wait for clearer confirmation of the bullish thesis, such as a stabilization above $180 or a positive earnings surprise.
COKE is more suitable for a medium-to-long-term investment horizon (2+ years) for investors seeking to capture the potential valuation re-rating as earnings unfold. Its low beta of 0.60 and defensive business model support a long-term hold. However, the extreme near-term volatility (-20.95% in one month) and lack of analyst coverage make it a poor candidate for short-term trading. The significant free cash flow generation and share repurchase activity are long-term value drivers. A minimum holding period of 2-3 quarters is recommended to allow for the next few earnings reports to clarify the forward earnings trajectory.
